- Tytuł:
- Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial
- Autorzy:
- Źródło:
- In The Lancet HIV May 2018 5(5):e211-e220
- Czasopismo naukowe